Abstract
THE rapid disappearance from circulation of human erythrocytes transfused to rats can be prevented if the animals are pretreated with ethyl palmitate (EP) and a cobra venom factor (CVF)1. The improvement in human erythrocyte survival in these animals is due to EP-induced impairment of reticuloendothelial function2 and to suppression of intravascular haemolysis through CVF inhibition of the third component of complement3. The halflife of normal human erythrocytes in the blood of untreated rats is less than 15 min, but is about 30 h in the EP and CVF treated rats4.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
